Veritas Pharma Provides Corporate Update
27. März 2019 08:00 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, March 27, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce corporate...
Veritas Confirms Readiness for Human Trials of CTL-X for Pain; Projected to Start Early Next Month
08. November 2018 08:30 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that, despite the...
Veritas Announces Investment Into Cannabis Growing Facility Under Health Canada License
23. Oktober 2018 08:15 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce a $1.25 million...
Veritas Pharma Signs MOU with Agrima Botanicals Corp. for a Medical Cannabis Research Collaboration
01. Oktober 2018 02:00 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Sept. 30, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered...
Veritas Signs MOU with Israeli Cannabis Industry Leader IsCann Group Limited
15. August 2018 16:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has signed a...
Veritas Pharma Announces Appointment of Accomplished Business Development and Strategy Professional, Justin Kausel
15. März 2018 03:15 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, March 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce that Justin Kausel has...
Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders
04. Januar 2018 17:24 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an update to its...
Dr. Brian O’Connor Joins Veritas Pharma Advisory Board
02. Januar 2018 03:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Brian O’Connor,...
Veritas’ Research Arm Cannevert Signs a Material Transfer Agreement with the Institute for Medical Cannabis of Puerto Rico
05. Dezember 2017 03:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces its research arm, Cannevert...
Cannevert Scientists to Present Their First Peer-Reviewed Research at December’s Prestigious British Pharmacological Society Meeting in London, UK
22. November 2017 16:15 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that the scientists of its research...